Clinical trial
To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds…
NCT00398099 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00398099 |
|---|---|
| Title | To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052) |
| Official title | Clinical Evaluation for the Efficacy, Safety, Tolerability & Medical Resource Utilization of Invanz (Ertapenem Sodium) Therapy |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Pneumonia, Urinary Tract Infection |
| Intervention type | Drug |
| Interventions | MK0826, ertapenem sodium / Duration of Treatment: 14 Days |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Nov 10, 2006 |
| Last update posted | Feb 17, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: